The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Protocol-specified final analysis of the phase 3 KEYNOTE-048 trial of pembrolizumab (pembro) as first-line therapy for recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC).
 
Danny Rischin
No Relationships to Disclose
 
Kevin J. Harrington
No Relationships to Disclose
 
Richard Greil
No Relationships to Disclose
 
Denis Soulieres
No Relationships to Disclose
 
Makoto Tahara
No Relationships to Disclose
 
Gilberto de Castro
No Relationships to Disclose
 
Amanda Psyrri
No Relationships to Disclose
 
Neus Baste
No Relationships to Disclose
 
Prakash C. Neupane
No Relationships to Disclose
 
Ase Bratland
No Relationships to Disclose
 
Thorsten Fuereder
No Relationships to Disclose
 
Brett Gordon Maxwell Hughes
No Relationships to Disclose
 
Ricard Mesia
No Relationships to Disclose
 
Nuttapong Ngamphaiboon
No Relationships to Disclose
 
Tamara Rordorf
No Relationships to Disclose
 
Wan Zamaniah Wan Ishak
No Relationships to Disclose
 
Yayan Zhang
No Relationships to Disclose
 
Fan Jin
No Relationships to Disclose
 
Burak Gumuscu
No Relationships to Disclose
 
Barbara Burtness
No Relationships to Disclose